A Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

May 31, 2007

Conditions
Healthy
Interventions
DRUG

Hylenex

Sponsors
All Listed Sponsors
lead

Halozyme Therapeutics

INDUSTRY